Belpointe Asset Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-50
Closed -$4K 2087
2023
Q1
$4K Buy
50
+9
+22% +$721 ﹤0.01% 3095
2022
Q4
$3.25K Buy
+41
New +$3.25K ﹤0.01% 3086